Catalyst Wire Dossier Catalyst Wire Dossier

iGlar

insulin glargine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for iGlar, covering 2025-12-10 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease [Phase 4]

See pricing